by Shana Cristoferi | May 21, 2020 | Appili Therapeutics, News
Read original here Appili Therapeutics Inc., a biopharmaceutical company focused on anti-infective drug development, today announced that Health Canada provided regulatory clearance for Appili’s Phase 2 study evaluating FUJIFILM Toyama Chemical’s (FFTC) favipiravir as...
by Shana Cristoferi | May 19, 2020 | Densitas Inc., News
Read original here Mo Abdolell is CEO/Founder of Densitas Inc., a company focused on the mammography enterprise that delivers machine learning solutions for personalized breast health with technologies focused on breast density, clinical image quality, tailored risk....
by Shana Cristoferi | May 15, 2020 | IMV Inc., News
Read original here IMV Inc., a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases, today announced financial results for the first quarter ended March 31, 2020 and provided an update on...
by Shana Cristoferi | May 14, 2020 | Adaptiiv, News
Read original here Eckert Ziegler BEBIG (EZB) and Adaptiiv Medical Technologies Inc. (Adaptiiv) are pleased to announce an extension of their strategic partnership. EZB will resell Adaptiiv’s 3D printing software solution in select markets that include Germany,...
by Shana Cristoferi | May 7, 2020 | IMV Inc., News
Read original here IMV Inc. a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines to fight against infectious diseases including COVID-19, today announced that it has completed its previously announced non-brokered...
